Published in Cancer on November 01, 1993
Neuroblastoma tumour genetics: clinical and biological aspects. J Clin Pathol (2001) 1.03
Thoracic neuroblastoma: outcome of incomplete resection. Pediatr Surg Int (2004) 0.93
The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma. Int J Cancer (2016) 0.81
Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature (1995) 11.06
Hydrogen peroxide metabolism in human monocytes during differentiation in vitro. J Clin Invest (1981) 4.46
Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis (2001) 4.06
Solid phase synthesis and restriction endonuclease cleavage of oligodeoxynucleotides containing 5-(hydroxymethyl)-cytosine. Nucleic Acids Res (1997) 3.54
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene (1999) 3.32
Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med (1998) 3.23
Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene (1997) 2.80
A simple method for counting adherent cells: application to cultured human monocytes, macrophages and multinucleated giant cells. J Immunol Methods (1983) 2.75
Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med (1999) 2.51
Amplified, frequency swept lasers for frequency domain reflectometry and OCT imaging: design and scaling principles. Opt Express (2005) 2.48
Lymphokines enhance the capacity of human monocytes to secret reactive oxygen intermediates. J Clin Invest (1982) 2.23
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer (2009) 2.13
Increase of solubility of foreign proteins in Escherichia coli by coproduction of the bacterial thioredoxin. J Biol Chem (1995) 2.05
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene (2000) 2.04
Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma. Hepatology (1998) 1.97
Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery (1984) 1.86
A mouse model of a human multiple GIST family with KIT-Asp820Tyr mutation generated by a knock-in strategy. J Pathol (2008) 1.78
Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma. Oncogene (2010) 1.65
Human T lymphocytes and monocytes bear the same Leu-3(T4) antigen. J Immunol (1986) 1.65
Congenital primitive neuroectodermal tumor with epithelial and glial differentiation. An ultrastructural and immunohistochemical study. Arch Pathol Lab Med (1990) 1.65
RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res (1998) 1.62
Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood (1995) 1.62
Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta. J Immunol (2001) 1.62
Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer (1990) 1.61
Allelotype study of primary hepatocellular carcinoma. Cancer Res (1991) 1.61
Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers. Br J Cancer (2008) 1.58
A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res (1993) 1.55
Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases. Oncogene (1999) 1.54
Real-time ultrasonographic assessment of antroduodenal motility after ingestion of solid and liquid meals by patients with functional dyspepsia. J Gastroenterol Hepatol (2000) 1.54
Development and validation of an ultrasonographic activity index of Crohn's disease. Eur J Gastroenterol Hepatol (1999) 1.51
Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology (1997) 1.50
A monoclonal antibody (MSN-1) against a newly established uterine endometrial cancer cell line (SNG-II) and its application to immunohistochemistry and flow cytometry. Am J Obstet Gynecol (1989) 1.49
Spontaneous release of the Leu-2 (T8) molecule from human T cells. J Exp Med (1983) 1.48
Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology (1993) 1.48
Rapid somatic growth after birth in children with neuroblastoma: A survey of 1718 patients with childhood cancer in Kyushu-Okinawa district. J Pediatr (1999) 1.47
Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology (2001) 1.46
Evaluation of cardiac sympathetic nervous function by 123I-metaiodobenzylguanidine scintigraphy in insulin-treated non-insulin dependent diabetics with hypoglycemia unawareness. Intern Med (1996) 1.43
Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene (1994) 1.41
Features and outcome of advanced neuroblastoma with distant lymph node metastasis. Pediatr Hematol Oncol (1992) 1.41
Evaluation of the Pentax-AWS(®) and the Macintosh laryngoscope in difficult intubation: a manikin study. Acta Anaesthesiol Scand (2011) 1.40
Results of surgical treatments of primary hepatocellular carcinoma: some aspects to improve long-term survival. World J Surg (1984) 1.39
Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res (1998) 1.39
Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma. J Pediatr Hematol Oncol (1999) 1.35
Therapeutic administration of anti-PcrV F(ab')(2) in sepsis associated with Pseudomonas aeruginosa. J Immunol (2001) 1.35
Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains. J Biol Chem (1999) 1.34
Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection? Cancer (1992) 1.32
Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature. Oncogene (2007) 1.31
p53 family genes: structural comparison, expression and mutation. Cell Death Differ (1999) 1.31
A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg (1984) 1.30
Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood (1994) 1.29
CD133 suppresses neuroblastoma cell differentiation via signal pathway modification. Oncogene (2010) 1.28
CD24 induces apoptosis in human B cells via the glycolipid-enriched membrane domains/rafts-mediated signaling system. J Immunol (2001) 1.25
Value of MR cholangiopancreatography in evaluating choledochal cysts. AJR Am J Roentgenol (1998) 1.24
Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance. J Biol Chem (2001) 1.24
Index matching to improve optical coherence tomography imaging through blood. Circulation (2001) 1.24
Neuroblastoma. Effect of genetic factors on prognosis and treatment. Cancer (1992) 1.23
A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res (1996) 1.23
Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma. Cancer (1997) 1.23
p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene (1999) 1.22
Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol (2000) 1.20
A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg (1994) 1.19
Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function. J Clin Invest (2001) 1.19
Synthesis and characterization of isotopically enriched pyrimidine deoxynucleoside oxidation damage products. Chem Res Toxicol (1998) 1.18
Role of c-kit receptor tyrosine kinase in development of oval cells in the rat 2-acetylaminofluorene/partial hepatectomy model. Hepatology (1999) 1.17
Focal adhesion kinase is not essential for in vitro and in vivo differentiation of ES cells. Biochem Biophys Res Commun (1995) 1.17
Retracted Intrahepatic metastases in hepatocellular carcinoma: evidence for spread via the portal vein as an efferent vessel. Am J Gastroenterol (1996) 1.16
Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma. Hepatology (1997) 1.14
Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice. Oncogene (2001) 1.14
Immunochemical analysis of the released Leu-2 (T8) molecule. J Exp Med (1984) 1.13
Reasonable explanation for both the antiandrogenic mechanism of DBP and DBP-induced Leydig cell hyperplasia in prenatally DBP-treated rats. Toxicol Appl Pharmacol (2000) 1.12
New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning. Cancer Res (1992) 1.11
p73, a gene related to p53, is not mutated in esophageal carcinomas. Int J Cancer (1998) 1.11
Expression of TrkA, TrkB and TrkC in human neuroblastomas. J Neurooncol (1997) 1.11
Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel. Clin Exp Metastasis (1996) 1.11
Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection. J Gastroenterol Hepatol (2000) 1.10
Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line. Oncogene (2000) 1.09
Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. Clin Cancer Res (2001) 1.09
Long-term results of hepatic portoenterostomy for biliary atresia: special reference to postoperative portal hypertension. Surgery (1974) 1.09
Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine endometrial cancers. Ann Oncol (2003) 1.09
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project. Br J Cancer (2012) 1.09
Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants. Cancer Lett (2001) 1.08
Role of survivin, whose gene is mapped to 17q25, in human neuroblastoma and identification of a novel dominant-negative isoform, survivin-beta/2B. Med Pediatr Oncol (2000) 1.07
Factors regulating tumor pressure in hepatocellular carcinoma and implications for tumor spread. Hepatology (1997) 1.07
Experience with International Neuroblastoma Staging System and Pathology Classification. Br J Cancer (2002) 1.06
Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas. J Immunol (1984) 1.06
Patterns of enteric nervous distribution after small bowel transplantation. Transplant Proc (1992) 1.06
Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2. J Infect Dis (1998) 1.06
Surgical strategy for the treatment of pyriform sinus fistula. J Pediatr Surg (1997) 1.05
Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma. Gynecol Oncol (2001) 1.05
Expression of TrkC in favorable human neuroblastomas. Oncogene (1996) 1.05